MRE11A |
MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
3.855 |
Evidence |
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
NCOA3 |
IPI00220082 |
3.855 |
Evidence |
|
CP |
CP: Ceruloplasmin precursor |
RNASE4 |
ANG, RNASE5: Angiogenin precursor |
3.855 |
Evidence |
|
STRN3 |
STRN3, GS2NA, SG2NA: Striatin-3 |
PCAF |
PCAF: Histone acetyltransferase PCAF |
3.855 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
3.855 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MYBBP1A |
MYBBP1A, P160: Myb-binding protein 1A |
3.855 |
Evidence |
|
HSP90AB1 |
HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
3.855 |
Evidence |
|
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
PTMA |
IPI00015550 |
3.855 |
Evidence |
|
RELA |
RELA, NFKB3: Transcription factor p65 |
TERF2 |
TERF2, TRBF2, TRF2: Telomeric repeat-binding factor 2 |
3.855 |
Evidence |
|
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
3.855 |
Evidence |
|
FLNA |
FLNA, FLN, FLN1: Filamin-A |
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
3.855 |
Evidence |
|
CP |
CP: Ceruloplasmin precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
3.855 |
Evidence |
|
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
3.855 |
Evidence |
|
DDX24 |
DDX24: ATP-dependent RNA helicase DDX24 |
RBM28 |
RBM28: RNA-binding protein 28 |
3.855 |
Evidence |
|
KIAA0690 |
IPI00101186 |
RBM28 |
RBM28: RNA-binding protein 28 |
3.855 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
3.855 |
Evidence |
|
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
3.855 |
Evidence |
|
TP53 |
TP53, P53: Cellular tumor antigen p53 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
3.855 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
PHF10 |
IPI00107282 |
3.855 |
Evidence |
|
TPT1 |
TPT1: Translationally-controlled tumor protein |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
3.855 |
Evidence |
|
WASPIP |
IPI00552369 |
JUNB |
JUNB: Transcription factor jun-B |
3.855 |
Evidence |
|
PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
DDX24 |
DDX24: ATP-dependent RNA helicase DDX24 |
3.855 |
Evidence |
|
COPB2 |
COPB2: Coatomer subunit beta' |
FER1L3 |
FER1L3, KIAA1207, MYOF: Myoferlin |
3.855 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
3.855 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
SIRT1 |
SIRT1, SIR2L1: NAD-dependent deacetylase sirtuin-1 |
3.855 |
Evidence |
|